INTRODUCTION
Development of thymocytes and their selection occurs in discreet steps in the thymus. It has become increasingly clear that various cell surface proteins on T lymphocytes interacting with their ligands on the stromal cells are critical for these processes (1) . A key set of proteins involved in the thymic development is the TCR/CD3 complex and antigen coreceptors (CD4 and CD8) (2, 3) . For example, expression of TCR-beta (pre-TCR complex) is critical for CD4-CD8-to CD4+CD8 / cell development (2, 3) . Expression of TCR-alpha-beta is critical for further development into either CD4/CD8 helper T cells or
CD4-CD8
/ cytotoxic T cells (3) (4) (5) . The ThB is a member of the Ly-6 multigene family expressed on thymocytes, B cells, and keratinocytes (6) (7) (8) (9) . Similar to other known members of the Ly-6 multigene family, ThB is 10-12 kDa in molecular mass and linked to the cell surface by a GPI-anchor (10, 11) . Although the biological function of the ThB molecule is unknown, recent reports indicate that the human homologue of ThB (E48) has cell-cell adhesion function in keratinocytes (9) . These latter observations are consistent with the cell adhesion properties reported for other members of the Ly-6 gene family (12) (13) (14) .
A distinct feature of some Ly-6 proteins is their regulated expression during the development of hematopoietic cells (11, 15) . For example, Ly-6A.2 is expressed on stem cells (16, 17) as well as on the a CD44 / subset of CD4-CD8-CD3-T cells in the thymus (18) . Ly-6A.2 is absent on the the majority of immature thymocytes including the CD4+CD8 / subset but reexpressed on mature T cells in the thymus and spleen (19) . In this regard, approximately 50 We sought to examine ThB expression in BALB/c mice for each of the four thymic subsets defined by anti-CD4 and anti-CD8 antibodies ( Figure 1A ). Figure 7A ). The downregulation of ThB was specific because expression of HSA was not altered in these mice ( Figure 7B ). This expression is not altered in MHC-deficeint mice injected with saline (controls) ( Figure 7A) (28) . HSA is highly expressed on the majority of DP thymocytes and is down regulated in the majority of mature T cells in the medulla (29) . Moreover, up regulation of CD69 seems to correlate with the maturation of DP thymocytes to the SP cell stage (30) . Only 10% of CD4+CD8 / thymocytes upregulate CD69 and audition for T-cell antigen receptor mediated positive selection (30, 31) . The level of ThB can be used to further dissect this subset of thymocytes. Therefore ThB expression defines unique subset with in the T cell subset (CD4/CD8+) in the thymus of normal mice known to undergo thymic selection. Isolation and characterization of this subset will provide further insights into T cell development in the thymus.
Although it is noteworthy that the expression of a number of Ly-6 molecules fluctuate during T cell development in the thymus, how this regulation occurs is unknown. Here we describe, that one factor which contributes to the regulation of Ly-6 ThB is These results suggest that antigen receptor and coreceptor ligation is necessary for downmodulation of ThB. It is possible that additional proteins expressed on CD4/CD8 / T cells including ThB as well as other cell-autonomous mechanisms may also contribute to the downmodulation of ThB.
Previous studies indicate that addition of anti-CD3 and anti-CD4 antibodies to fetal thymi from MHC class I-II-mice results in maturation of CD4 + T cells and downregulates the expression of HSA from HSA laigh to HSA lw therefore suggesting that these cells have undergone positive selection. In contrast, our studies in which anti-CD3 and anti-CD4 antibodies are injected in vivo does not result in maturation of CD4 / helper T cells. Moreover, the expression of HSA also remains unaltered in these injected mice. These different results may be attributed to the different experimental systems used (i.e. fetal thymic organ culture Vs injection into the mice) or differences in the amount of antibodies reaching thymocytes under these different experimental conditions. .Interestingly, injection of anti-CD3 and anti-CD4 antibodies in MHC class I-II-mice cause downregulation of ThB expression on CD4+CD8 + thymocytes.
These later observations may suggest that anti-CD3+anti-CD4 antibodies do not provide sufficient ligation for full positive selection to proceed but may initiate some initial events in this process (i.e. downregulation of ThB expression). These later results are consistent with other data that downregulation of ThB requires interaction of TCR and co-receptor with their ligand.
Previously published data have demonstrated two patterns of ThB expression (25) . Thymocytes from C57BL/6 mice show higher ThB expression, in comparison with thymocytes from BALB/c mice which are known to show lower levels of ThB. Our observations are consistent with these published results since only about 80% of CD4/CD8 / thymocytes express high levels of ThB in C57BL/6 mice as compared to 50-60% in BALB/c mouse. These differences do not arise from expression of different alleles in these two mouse strains (32) . The genetic basis of these differences is not known. The genetic variation of ThB expression has not been mapped to H-2 locus and therefore lack of I-E expression in C57BL/6 is unlikely to influence ThB expression (6 (33) suggests that downmodulation of ThB occurs prior to disappearance of cells by negative selection and may be the result of first and initial interaction of TCR/coreceptor with self-MHC+pep-tide as previously proposed (34) .
This data also suggests that a.high percentage of DP thymocytes that have rearranged their TCR react with self-MHC-peptide complexes that results in downmodulation of ThB expression. These results are consistent with other recent observations that T cell repertoire that exists prior to thymic selection is highly biased in its reactivity to MHC molecules (35) (36) (37) . The data presented in here are consistent with our previous estimates that indicate that this reactivity is atleast in the range of 10-15% (35 (4) (generously provided by Dr. Lauri Glimcher) were used in this study. Mice were bred at the University of Georgia animal facility and used between the ages of 4-10 weeks for the experiments.
Cell Preparations and Immunofluorescence
Cell were prepared from lymphoid organs (thymus, spleen) and stained with fluorochrome conjugated antibodies according to previously published protocols (24) . Briefly, cells were stained with conjugated antibodies, phycoerythrin (PE) anti-CD4 antibody (H129.19), fluoroscein isothiocyanate (FITC) anti-CD8, biotin-anti-ThB (49-H4) followed by Streptavidin-Red 613 TM (Gibco-BRL). In some experiments thymocytes and splenocytes were stained with 145-2Cll (anti-CD3), 53.9.2 (anti-ThB) followed by goat anti-rat IgG-FITC. Cells were fixed with paraformaldehyde (1% final concentration) before analysis by cytoflourometery (Coulter Epics Elite).
In vivo modulation of ThB expression
Purified anti-CD3 (145-2Cll), anti-CD4 (GK1.5), Hamster IgG (9-A2A4) (50 ug/each) or saline was injected intraperitoneally in 4-8 week old MHC class I-II-mice in a volume of 100 ul. The mice were sacrified 2-6 days post injection and cellularity of the thymus was determined followed by analysis by immunofluorescence and flow cytometery.
